Articles related to PATIENT SAFETY

The FDA classified a recall of dorzolamide and timolol ophthalmic solution as a Class II event after reports of defective containers, affecting a specific lot used to treat glaucoma and ocular hypertension.

The FDA classified a recall of 39,060 bottles of Clear Eyes Maximum Itchy Eye Relief as a Class II event after the manufacturer identified sterility concerns and potential contamination affecting a single lot.

Testimony from a psychiatrist in the Lindsay Clancy murder trial has highlighted how clinical documentation, incomplete information, and retrospective interpretation of psychiatric records can become central evidence in legal proceedings without resolving underlying questions of diagnosis or criminal responsibility.

Tranexamic acid was associated with lower rates of major bleeding among patients undergoing urologic surgery in a prespecified POISE-3 trial analysis, while thrombotic event rates remained similar between treatment groups.

The New Mexico Supreme Court ruled that a patient’s statements to a physician remained protected by physician-patient privilege despite police presence during a clinical conversation. The decision arose from a newborn death prosecution and highlights the fact-specific nature of confidentiality protections.

A Georgia woman alleges that a pathology specimen mix-up led to an erroneous cancer diagnosis and an unnecessary hysterectomy. The lawsuit highlights the potential consequences of laboratory identification failures and diagnostic verification breakdowns.